• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

Public
KYMR
United States
SectorHealthcare
CountryUnited States
Market cap7.07B
A clinical-stage biopharmaceutical company pioneering targeted protein degradation to discover medicines for immune-inflammatory diseases and oncology.

Where to buy Kymera Therapeutics, Inc. (KYMR)

KYMR trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare